Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

2.

Genetic predisposition of life-threatening antiepileptic-induced skin reactions.

Chung WH, Hung SI, Chen YT.

Expert Opin Drug Saf. 2010 Jan;9(1):15-21. doi: 10.1517/14740330903427969. Review.

PMID:
20001755
3.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
4.

Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.

Locharernkul C, Shotelersuk V, Hirankarn N.

J Clin Neurosci. 2011 Oct;18(10):1289-94. doi: 10.1016/j.jocn.2010.12.054. Epub 2011 Jul 28. Review.

PMID:
21802305
5.

Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W.

JAMA Dermatol. 2013 Sep;149(9):1025-32. doi: 10.1001/jamadermatol.2013.4114. Review.

PMID:
23884208
6.

[Exploratory studies on genetic biomarkers related to serious drug adverse reactions].

Kaniwa N, Hasegawa R.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2009;(127):1-14. Review. Japanese.

PMID:
20306701
7.

Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.

Chung WH, Hung SI.

Allergol Int. 2010 Dec;59(4):325-32. doi: 10.2332/allergolint.10-RAI-0261. Epub 2010 Oct 25. Review.

8.

[Exploratory study on biomarkers associated with severe cutaneous adverse reactions].

Kaniwa N.

Yakugaku Zasshi. 2011 Feb;131(2):255-61. Review. Japanese.

9.

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, Connolly MB, Ito S, Carleton BC; CPNDS clinical recommendation group.

Epilepsia. 2014 Apr;55(4):496-506. doi: 10.1111/epi.12564. Epub 2014 Mar 5. Review.

10.

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Review.

11.

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N.

BMC Med Genet. 2011 Sep 9;12:118. doi: 10.1186/1471-2350-12-118. Review.

12.

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.

Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A.

Clin Pharmacol Ther. 2012 Dec;92(6):757-65. doi: 10.1038/clpt.2012.189. Epub 2012 Nov 7. Review.

PMID:
23132554
13.

Human leukocyte antigens and drug hypersensitivity.

Chung WH, Hung SI, Chen YT.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):317-23. Review.

PMID:
17620823
14.

Pharmacogenetics of toxic epidermal necrolysis.

Lee MT, Hung SI, Wei CY, Chen YT.

Expert Opin Pharmacother. 2010 Sep;11(13):2153-62. doi: 10.1517/14656566.2010.495120. Review.

PMID:
20536296
15.

HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.

Grover S, Kukreti R.

Pharmacogenet Genomics. 2014 Feb;24(2):94-112. doi: 10.1097/FPC.0000000000000021. Review. Erratum in: Pharmacogenet Genomics. 2014 Apr;24(4):230.

PMID:
24336023
16.

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.

Chung WH, Hung SI.

J Dermatol Sci. 2012 Jun;66(3):190-6. doi: 10.1016/j.jdermsci.2012.04.002. Epub 2012 Apr 11. Review.

PMID:
22541332
17.

[Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].

Halevy S.

Harefuah. 2010 Mar;149(3):186-90, 193. Review. Hebrew.

PMID:
20684173
18.

T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.

Ko TM, Chen YT.

Expert Rev Clin Immunol. 2012 Jul;8(5):467-77. doi: 10.1586/eci.12.31. Review.

PMID:
22882221
19.

Stevens-Johnson syndrome induced by acetazolamide.

Her Y, Kil MS, Park JH, Kim CW, Kim SS.

J Dermatol. 2011 Mar;38(3):272-5. doi: 10.1111/j.1346-8138.2010.00921.x. Epub 2010 Dec 13. Review.

PMID:
21342230
20.

Lamotrigine-induced severe cutaneous adverse reactions.

Schlienger RG, Shapiro LE, Shear NH.

Epilepsia. 1998;39 Suppl 7:S22-6. Review.

Items per page

Supplemental Content

Write to the Help Desk